XML 54 R49.htm IDEA: XBRL DOCUMENT v3.20.1
Commitments and Contingencies (Details Narrative)
$ / shares in Units, ₪ in Thousands
1 Months Ended 12 Months Ended
Feb. 04, 2020
USD ($)
Apr. 28, 2019
USD ($)
May 24, 2018
shares
Apr. 10, 2018
USD ($)
shares
Jan. 04, 2018
USD ($)
$ / shares
Jan. 04, 2018
ILS (₪)
Sep. 30, 2018
USD ($)
Jul. 31, 2018
USD ($)
Apr. 30, 2018
USD ($)
Jun. 30, 2012
Dec. 31, 2019
USD ($)
shares
Monthly consultation fee in USD | $ / shares         $ 11.50            
Subsequent Event [Member] | Joseph Mona [Member]                      
Settlement amount $ 151,000                    
Alliance Investment Management, Ltd. [Member]                      
Litigation settlement   $ 480,000                  
CardioSert Ltd [Member]                      
Initial payment       $ 250,000 $ 50,000            
Number of common shares acquired | shares     6,738 6,738              
Number of common shares acquired, value       $ 74,000              
Buy back amount per patent | $ / shares         $ 1.00            
CardioSert Ltd [Member] | Before Reverse Split [Member]                      
Number of common shares acquired | shares     100,000 100,000              
Securities Purchase Agreement [Member]                      
Settlement amount                     $ 3,700,000
Number of post-stock split shares returned | shares                     83,333
Purchase price of plaintiffs                     $ 6,750,000
Minimum [Member] | Alliance Investment Management, Ltd. [Member]                      
Beneficial ownership percentage   10.00%                  
Minimum [Member] | CardioSert Ltd [Member]                      
Investments         $ 2,000,000            
Minimum [Member] | Technion Research and Development Foundation Limited [Member]                      
Royalties payable as percentage of future sales                   1.50%  
Maximum [Member] | Technion Research and Development Foundation Limited [Member]                      
Royalties payable as percentage of future sales                   3.00%  
Second Phase [Member] | Contract Research Agreements [Member]                      
Contract expected costs             $ 248,000   $ 130,000    
Phase 2.1 [Member] | Contract Research Agreements [Member]                      
Contract expected costs               $ 213,000      
NIS [Member]                      
Monthly consultation fee | ₪           ₪ 40          
Currency exchange rate, description         Exchange rate of NIS3.47 to the dollar Exchange rate of NIS3.47 to the dollar          
Israeli Innovation Authority [Member] | 2013 Through December 31, 2019 [Member]                      
Total grants obtained                     $ 1,500,000
Israeli Innovation Authority [Member] | 2013 Through December 31, 2019 [Member] | Minimum [Member]                      
Royalties payable as percentage of future sales                     3.00%
Israeli Innovation Authority [Member] | 2013 Through December 31, 2019 [Member] | Maximum [Member]                      
Royalties payable as percentage of future sales                     3.50%